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Abstract
NFIL3 (nuclear factor, IL-3 regulated) is a transcription factor that regulates multiple
immunologic functions. In myeloid cells, NFIL3 is IL-10 inducible, and has a key role as a
repressor of IL-12p40 transcription. NFIL3 is a susceptibility gene for the human inflammatory
bowel diseases. Here we describe spontaneous colitis in Nfil3−/− mice. Mice lacking both Nfil3
and Il10 (NIDKO) had severe early-onset colitis, suggesting NFIL3 and IL-10 independently
regulate mucosal homeostasis. Lymphocytes were necessary for colitis, as Nfil3/Rag1 double
knockout (NRDKO) mice were protected from disease. However, NRDKO mice adoptively
transferred with wild type CD4+ T cells developed severe colitis compared to Rag1−/− recipients,
suggesting that colitis was linked to defects in innate immune cells. Colitis was abrogated in Nfil3/
Il12b double-deficient mice, identifying Il12b dysregulation as a central pathogenic event. Finally,
germ-free Nfil3−/− mice do not have colonic inflammation. Thus, NFIL3 is a microbiota-
dependent, IL-10-independent regulator of mucosal homeostasis via IL-12p40.
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INTRODUCTION
Genetic variants that confer susceptibility to the human inflammatory bowel diseases (IBD),
Crohn’s disease (CD) and ulcerative colitis (UC) highlight the importance of innate immune
interactions with the enteric microbiota in controlling inflammation (1). A consequence of
innate immune activation in IBD is the over-production of, and maladaptive responses to,
pro-inflammatory cytokines (2). In this context of human IBD and mouse models of IBD,
IL-12 and IL-23 have been shown in multiple contexts to have a central pathogenic role (3–
7). IL-12 and IL-23 are heterodimeric cytokines composed of p40-p35 and p40-p19
subunits, respectively. Macrophages and dendritic cells activated by microbes and microbial
products are the main cell types that produce IL-12 and IL-23. While IL-12 is decisive in
regulating lineage commitment to Th1 development, IL-23 is essential for the maturation
and stability of Th17 cells (8, 9). Several genes in the IL-12 and IL-23 expression and
signaling pathways, notably IL23R, JAK2, STAT3, and IL12B are associated with CD and
UC susceptibility (10, 11).
A key step in the normal homeostatic regulation of IL-12 and IL-23 from activated innate
cells is inhibition by IL-10 derived from autocrine-paracrine signaling from activated
myeloid cells, or from lymphocytes, especially regulatory T cells (12, 13). IL-12 and IL-23
are not the only IL-10 targets; in fact many pro-inflammatory genes implicated in IBD,
including TNF and IL1B, are regulated by IL-10 by a variety of mechanisms (14, 15).
However, in the context of intestinal mucosal homeostasis, the IL-10-mediated inhibitory
pathway that tonically regulates excessive IL-12 and IL-23 is a central pathway. Defects in
the production of or the responsiveness to IL-10 exert profound homeostatic effects in the
mucosal immune system (12, 16, 17). Polymorphisms in IL10 confer susceptibility to UC
while complete loss-of-function mutations in the IL-10 receptors cause a rare but severe
form of very early onset of IBD (18, 19). Importantly, ablation of IL-12 and IL-23
significantly ameliorates IBD in the IL-10-deficient (Il10−/−) mouse model, confirming the
essential role of the IL-10 inhibitory pathway that controls IL-12 and IL-23 (20–22).
The basic leucine zipper transcription factor NFIL3 (Nuclear factor, IL-3 regulated, also
known as E4BP4) has recently been implicated as a regulator of multiple aspects of immune
function. NFIL3 is essential for the development of all natural-killer (NK) cells (23, 24) and
CD8α dendritic cells (DCs) (25), cytokine production by Th2 cells (26, 27), and IgE class-
switching in B cells (28). IL-10 was reported to regulate NFIL3 mRNA expression over a
decade ago (29). Following from that observation, we recently reported that NFIL3 is an
essential transcriptional repressor of IL-12p40 in murine macrophages (30, 31). NFIL3
controls Il12b transcription by binding to an enhancer located ~10 kb upstream of the
canonical Il12b promoter (31). An NFIL3 binding element has also been characterized in the
proximal Il12b promoter region (30). Myeloid cells deficient in NFIL3 overproduce
IL-12p40, however, they remain responsive to IL-10-mediated inhibition, arguing that
NFIL3 is a necessary component of the IL-10 pathway but alone is not sufficient to block
IL-12p40 production (30, 31). We also found that NFIL3 participates in host enteric
microbial interactions in vivo and the enteric microbiota and IL-10 are co-factors for NFIL3
expression in the intestine. We found that colonic CD11b+ LPMC isolated from Nfil3−/−
mice, like bone marrow-derived myeloid cells, made higher amounts of Il12b mRNA than
WT CD11b+ colonic macrophages. In human IBD, intestinal CD14+ macrophages are major
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producers of pro-inflammatory cytokines including IL-12 family members (5). We found
that NFIL3 expression was lower in CD14+ LPMC isolated from patients with CD and UC
compared with non-inflammatory controls undergoing surgical resection (30). Our previous
studies also concluded that intestinal NFIL3 expression inversely correlates with higher
amounts IL-12p40 in mice and humans (30). Importantly, recent meta-analysis of CD and
UC genome-wide association scans identified NFIL3 as a susceptibility gene for human
inflammatory bowel disease (IBD) (32).
Collectively, these studies raised the possibility that NFIL3 would be involved in normal
homeostatic regulation of the intestine. Here, we characterize a severe form of spontaneous
colitis in Nfil3−/− mice that correlated with increased IL-12p40 in serum and colonic tissue.
Colitis was dependent on Il12b-driven innate and adaptive immune interactions. These
results implicate NFIL3 as a central determinant of mucosal immune homeostasis and




Nfil3−/− mice were generated by gene-targeting strategies as reported (28) and bred with
C57BL/6 mice for at least 10 generations. Germ free (GF) Nfil3−/− mice were Caesarian
derived as previously described (33) and were maintained according to standard techniques
in the University of North Carolina National Gnotobiotic Resource Center. WT, Il10−/−, and
Rag1−/− mice were obtained from Jackson Laboratory (Bar Harbor, ME). Il10−/− and
Rag1−/− mice were crossed with Nfil3−/− mice to generate mice deficient in both genes
(Nfil3−/−Il10−/−, NIDKO or Nfil3−/−Rag1−/−, NRDKO). All experimental mice were
genotyped by polymerase chain reaction (PCR) screening before tissue collection, and age-
matched littermates were used as controls. Mice were evaluated for colonic inflammation at
the age of 12–16 weeks. Another strain of NFIL3-deficient mice (24) was maintained at St.
Jude Children’s Research Hospital. All animal experiments were in accordance with
protocols approved by the Institutional Animal Care and Use Committee of the University of
North Carolina School of Medicine, the University of Iowa Carver College of Medicine and
St. Jude Children’s Research Hospital.
Reagents
LPS was purchased from InvivoGen (San Diego, CA). M-CSF was obtained from Peprotech
Inc (Rocky Hill, NJ).
Cell isolation
BMDMs were cultured as described (34). Mouse colonic lamina propria mononuclear cells
(LPMCs) were isolated by an enzymatic method and separated into CD11b+ cells using
MACS anti-CD11b microbeads (Miltenyi Biotec, Auburn, CA) (12).
Quantitative RT-PCR
Quantitative real-time RT-PCR was performed as described (35). Primer sequences are
available upon request.
Colonic tissue explant cultures and histology
Colonic tissue explant cultures were performed as previously described (35). Supernatants
were collected after 24 hours for cytokine ELISA. Cytokine values were normalized to dry
weight of the colonic tissue explants (pg/ml/100 mg). Slides were prepared for H&E
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staining and histological analysis was performed by a pathologist blinded to the study
groups (LBB) using criteria reported previously (36).
Flow cytometry
Flow cytometric analysis was performed as previously described (12). Anti-CD3, anti-CD4,
anti-NKp46, anti-retinoid-acid receptor-related orphan receptor gamma t (RORχt), anti-
forkhead box P3 (Foxp3), anti-IL-17A, and anti-IFN-γ antibodies were purchased from
eBioscience (San Diego, California, USA). For intracellular staining, Cytofix/Cytoperm Kit
(BD PharMingen) was used according to the manufacturer’s instructions. For cytokine
staining, LPMCs were stimulated with phorbol myristate acetate (100 ng/ml) and ionomycin
(1 μg/ml) (Sigma) in the presence of monensin (Golgistop; BD PharMingen) for 4 hours.
Results were analyzed by Beckman-Coulter (Dako) CyAn ADP flow cytometer and Summit
(version 4.3) software.
Immunohistochemistry
Mouse colonic tissues were harvested, swiss-rolled, and fixed with 4% paraformaldehyde
(Sigma, St. Louis, MO) overnight. Fixed tissues were then embedded in OCT compound
(Sakura, Tokyo, Japan) and kept at −80°C. Frozen tissue sections (7 μm) were first blocked
for 30 min at room temperature with Blocking Reagent (PerkinElmer, Waltham, MA) and
then incubated overnight at 4°C with primary antibodies as described below. Following
overnight incubation, sections were washed and then incubated with HRP-conjugated
secondary antibody for 1h at room temperature. After washing, sections were treated with
tyramide-fluorescein (PerkinElmer), followed by counterstaining with DAPI (Sigma). All
stained sections were analyzed by confocal microscope using either the 10× or the 20×
objective (TCS SP2, Leica, Wetzlar, Germany). Images were processed with Adobe
Photoshop software. The following antibodies were used: anti-CD11c and anti-F4/80 from
BD Bioscience (Franklin Lakes, NJ), anti-CD3, anti-NKp46, and anti-B220 from
eBioscience (San Diego, CA), HRP-conjugated donkey anti-rat IgG, and HRP-conjugated
donkey anti-Armenian hamster IgG (H+L) from Jackson Immunoresearch (West Grove,
PA).
ELISA
IL-12p40 concentration was determined by sandwich ELISA (BD Biosciences, San Jose,
CA). IL-22 ELISA kit was obtained from eBioscience (San Diego, CA). IL-17A, IL-10,
IFN-γ, and TNF-α were measured using the MILLIPLEX MAP Cytokine Kit (Millipore,
Billerica, MA).
Induction of colitis by adoptive transfer of T cells
Splenocytes from WT mice were enriched for CD4+ cells by positive selection on MACS
columns with anti-CD4 microbeads (Miltenyi Biotec). Rag1−/− or Nfil3−/−Rag1−/−
(NRDKO) mice were i.p. injected with 1×106 CD4+ cells. Recipients and control mice were
observed for clinical signs of colitis and body weight changes. Clinical score was recorded
four weeks post-transfer as previously described (37) (wasting: 0, no wasting; 1, 0.1–10%
loss of initial total body weight; 2, >10% loss of initial total body weight; diarrhea: 0, none;
1, soft stool; 2, watery and/or bloody; hunching/bristled fur/skin lesions: 0, unchanged; 1,
any positive sign; rectum prolapse: 0, absent; 1, present).
Germ free to conventionalized transition of mice
8–10-week-old GF WT and Nfil3−/− mice were transitioned to conventionalized housing. To
re-colonize the GF mice with conventionalized microbiota, each cage was given bedding
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from the same donor conventionalized WT cage. Mice were sacrificed after 2 weeks and
monitored for colitis as described above.
Statistical analysis
Statistical significance for data subsets was assessed by the two-tailed Student’s t test unless
specifically described. A p<0.05 was considered significant.
RESULTS
Nfil3−/− mice develop spontaneous Th1/Th17-mediated chronic colitis
On necropsy, colons from 12-week-old Nfil3−/− mice were thickened and foreshortened with
lack of formed fecal pellets. Colon length was significantly shorter in Nfil3−/− compared to
WT mice (Fig. 1A). Approximately 20% of Nfil3−/− mice developed rectal prolapse by 20
weeks and 50% by 36 weeks of age (Fig. 1B).
Quantitative assessment of colonic histology revealed markedly increased frequency and
severity of inflammation in Nfil3−/− mice compared to WT mice (Fig. 1C). As in other
models of spontaneous colitis, histological severity was variable and penetrance of disease
was incomplete (Fig. 1H Compared to colons from WT mice (Fig. 1D), significant
elongation of colonic crypts was observed colons from Nfil3−/− mice (Fig. 1E).
Inflammation was characterized by multifocal aggregates of inflammatory cells that were
confined to the mucosa as well as extending transmurally to the submucosa (Fig. 1F). We
also observed areas of ulceration (Fig. 1G, arrow). Inflammation in the lamina propria was
occasionally organized into de novo lymphoid follicles, and multinucleated giant cells were
detected (Fig. 1H, arrow). Quantitative assessment of colonic histological severity (n = 25,
12–16 week old Nfil3−/− mice) was significantly higher compared to age-matched WT mice
(n = 7), but the penetrance of colitis was incomplete (Fig. 1C).
Colonic tissue explants from Nfil3−/− mice secreted significantly elevated amounts of pro-
inflammatory cytokines IL-12p40, TNF-α, IFNγ and IL-17A compared to WT colonic
explants (Fig. 2A). Quantitative real-time RT-PCR from colonic tissue also demonstrated
increased mRNA expression for these cytokines (Fig. 2B). Serum IL-12p40, TNF-α, IFNγ
and IL-17A were also increased in Nfil3−/− mice (Fig. 2C). Increased colonic and serum
IL-10 was also detected, suggesting that the loss NFIL3-dependent pathways cannot be
compensated by increased IL-10 expression (Fig. 2A, B, C). Moreover, serum IL-12p40
positively correlated with colonic IL-12p40 expression (Fig. 2D) and histologic severity of
inflammation (Fig. 2E, F). Consequently, serum IL-12 p40 is a biomarker for histological
severity of colitis in this model.
Colonic macrophages are the main source of inflammatory cytokines in Nfil3−/− mice
By immunohistochemical analyses, CD3+, B220+. and F4/80+ cells were increased in
inflamed colonic lamina propria of Nfil3−/− mice compared to WT mice, with the most
striking increase in F4/80+ cells (Fig. 3A). There was no significant increase in CD11c+
dendritic cell (DC) populations. B220+ plasma cells were localized inside and outside of
secondary lymphoid follicles in Nfil3−/− mice in contrast to WT colons where the vast
majority of B220+ cells localized within lymphoid structures. CD11b+ lamina propria
mononuclear cells (LPMC) are comprised of colonic macrophages (F4/80+ CD11c− or
CD11clow) and DCs (CD11c+ F4/80−) (38). We therefore isolated and analyzed colonic
CD11b+ LPMCs from colons of Nfil3−/− as a representative colonic macrophage population.
Nfil3−/− CD11b+ colonic LPMCs expressed higher Il12b, Il23a, Tnf, and Il10 mRNA
compared to WT CD11b+ colonic LPMCs (Fig. 3B). Furthermore, these cytokine mRNAs
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were predominantly expressed in CD11b+ LPMCs, whereas expression in the CD11b−
population was limited.
Localization of IFNγ and IL-17A expression in CD3+CD4+ colonic lamina propria T cells
was examined by intracellular cytokine staining in WT and Nfil3−/− mice. Both IFN-γ- and
IL-17A-producing CD4+ T cells are significantly increased in Nfil3−/− mice (Fig. 3C, D).
The percentage of Foxp3+CD4+ regulatory T cells did not differ between WT and Nfil3−/−
colonic LPMCs (Fig. 3E).
Nfil3−/− mice have decreased numbers of colonic NK cells and lymphoid tissue inducer
cells (LTi)
Nfil3−/− mice lack peripheral NK1.1+ NK cells (23, 24). However it is unclear whether these
mice also lack intestinal NK cells, which express NKp46 (39). The lamina propria
CD3−NK1.1+ NK cell population was significantly decreased, while CD3+NK1.1+ NK T
cells were similar in number in Nfil3−/− compared to WT mice (Fig. 4A). The transcription
factor retinoid-acid receptor-related orphan receptor gamma t (RORγt) is implicated in NK
marker-expressing mucosal lymphoid cell development and function (39, 40). Therefore,
RORγt expression was assessed in the colonic NKp46+ cell population. Both RORγt+ and
RORγt− CD3−NKp46+ colonic lamina propria ILC populations were significantly decreased
in number in Nfil3−/− compared to WT mice (Fig. 4B). Lymphoid tissue inducer (LTi) cells,
defined as CD3− RORγt+, are required for the development of secondary lymphoid tissue in
the gut (41). In contrast to CD3+RORγt+ cells that include IL-17A-producing T cells, the
CD3− RORγt+ LTi population was significantly decreased in Nfil3−/− compared to WT
mice. Both CD4+ and CD4− populations were decreased among CD3−NKp46−RORγt+ LTi
cells in Nfil3−/− colons, even though de novo colonic mucosal lymphoid structures are
present in Nfil3−/− mice (Fig. 1H). RORγt+ CD3−NKp46+ mucosal lymphoid cells are a
major source of the homeostatic cytokine IL-22 (NK22 cells) (39, 40). Therefore, expression
and production of colonic IL-22 was examined in Nfil3−/− mice. By contrast to other pro-
and anti-inflammatory (IL-10) cytokines (Fig. 2A, B), IL-22 production in colonic explant
culture and Il22 mRNA expression were not increased in Nfil3−/− colonic tissue (Fig. 4C).
IL-10 and NFIL3 independently but cooperatively regulate IL-12p40 in BMDMs and in vivo
We have previously shown that IL-10 is required for LPS-induced NFIL3 expression in
BMDMs and that NFIL3 partly mediates IL-10 inhibition of Il12b (30, 31). Moreover,
Il10−/− mice demonstrated impaired induction of Nfil3 in the colon by the microbiota (30).
However, inhibition of Il12b by NFIL3 does not require IL-10, since overexpression of
NFIL3 in Il10−/− BMDMs effectively inhibited IL-12p40 (30). Therefore, whether IL-10
and NFIL3 independently regulate IL-12p40 in cells and in vivo was next addressed. The
inhibitory effect of IL-10 on IL-12p40 in WT and Nfil3−/− BMDMs was compared.
Recombinant IL-10 inhibited LPS-induced IL-12p40 to a similar extent in WT and Nfil3−/−
BMDMs (Fig. 5A). We next generated Nfil3 × Il10 double knockout (NIDKO) mice, and
hypothesized that colitis would be similar in severity in NIDKO mice compared to single
knockouts if NFIL3 and IL-10 functions are completely dependent on each other. IL-12p40
production from activated macrophages was dramatically increased in NIDKO BMDMs
compared to either single knockout cells (Fig. 5B). However, there was no difference in
IL-10 mediated IL-12p40 inhibition in Il10−/− and NIDKO BMDMs (Fig. 5C), suggesting
that inhibition of IL-12p40 by IL-10 does not require NFIL3. These data were ascertained
independently with BMDMs from two different strains of NIDKO and single knockout mice
derived at UNC and St. Jude Children’s Research Hospital.
Importantly, NIDKO mice had severe colitis with 100% penetrance (Fig. 5D) and higher
colonic IL-12p40 expression (Fig. 5E) at 5 weeks of age (when these mice were euthanized
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due to severity of illness) compared to single knockout mice at 12–16 weeks of age. All
double knockout mice developed severe diarrhea and 50% (3/6) developed rectal prolapse
by 5 weeks of age. By comparison, 7 and 12 percent of Il10−/− (n=28, data not shown) and
Nfil3−/− (n=41, see Fig. 1B), respectively, developed rectal prolapse in mice at 16 weeks of
age. Colon length was shorter in NIDKO mice compared to Nfil3−/− and Il10−/− mice (Fig.
5F). Interestingly, histological colonic inflammation was more severe in Nfil3−/− mice than
Il10−/− mice on a C57BL/6 background (Fig. 5D). A separate colony of NIDKO mice
generated at St. Jude Children’s Research Hospital confirmed these findings; even though
the St. Jude Nfil3−/− mice do not get colitis, combined loss of IL-10 and NFIL3 caused a
dramatic acceleration in colitis. These findings demonstrate that NFIL3 and IL-10
coordinately but independently regulate mucosal homeostasis.
Nfil3+/+ T cells are sufficient to induce colitis in Nfil3/Rag1 double knockout mice
In an adoptive transfer model of colitis in Rag1−/− recipients, Motomura et al.,
demonstrated that naive Nfil3−/− CD4+T cells were potent in colitis induction potential
compared to WT CD4+ T cells (27), mediated by defective IL-10 production from Nfil3−/− T
cells. However, since IL-10 production was increased in Nfil3−/− colons (Fig. 2A, B, C),
other mechanisms underlie colitis development in the Nfil3−/− background. Therefore,
Nfil3−/− mice were crossed to Rag1−/− mice (NRDKO) to study whether lymphocytes are
necessary for the colitis development in Nfil3−/− mice. NRDKO mice had no clinical signs
of colitis (data not shown). Colonic histological scores (Fig. 6A) and colonic IL-12p40 (Fig.
6B) were comparable to WT and Rag−/− mice, showing that lymphocytes are necessary for
colitis development.
We next asked whether innate-T cell interactions are necessary for the development of
colitis in Nfil3−/− mice. WT (Nfil3+/+) unfractionated CD4+ T cells were adoptively
transferred into Rag1−/− or NRDKO mice. Unfractionated CD4+ cells did not cause severe
pathology when transferred to Rag1 single knockout recipients (Fig. 6C–G), as previously
described (42). However, NRDKO recipients develop severe colitis clinically (Fig. 6C, D,
E) and histologically (Fig. 6F, G), correlating with increased intestinal IL-12p40 (Fig. 6H)
and IFN-γ (Fig. 6I). These results suggest that T cells are necessary for the development of
colitis in Nfil3−/− mice; however the lack of NFIL3 in accessory cell populations is essential
for intestinal inflammation. Furthermore, transferred Tregs in the unfractionated CD4+
population cannot rescue disease when NFIL3 is absent in non-lymphocyte cells.
Nfil3/Il12b double knockout mice do not develop colitis
Genetic deletion of Il12b rescues several forms of intestinal inflammatory disease because
IL-12 and IL-23 production is ablated (20, 43). Therefore, a key test of the relationship
between NFIL3 and IL-12p40 is to determine if loss of Il12b rescues colitis in Nfil3−/− mice.
We therefore generated Nfil3 × Il12b double knockout (DKO) mice and observed that these
mice did not develop colitis up to 4 months of age (Fig. 7A, B), confirming that increased
IL-12p40 production in Nfil3−/− mice is responsible for the development of colitis and of the
inflammatory T cell phenotype.
Colitis development in Nfil3−/− mice is dependent on the enteric microbiota
Nfil3−/− mice in our colony at the University of North Carolina develop significant
spontaneous colitis, but mice from the founder colony at the University of Iowa (28) and a
colony at St. Jude Children’s Research Hospital (31) do not develop colitis. Indeed, in a
histologic analysis of 14 Nfil3−/− mice 6–8 months in age from the University of Iowa and
St. Jude Children’s Research Hospital, no colitis was detected (data not shown), whereas 10
age-matched mice from the UNC colony manifest histologic colitis (data not shown). We
assayed for Helicobacter spp. in the feces of Iowa and UNC mice. Non-H. hepaticus (H.
Kobayashi et al. Page 7













hepaticus is routinely screened by both facilities) Helicobacter spp. were present in both
colonies (data not shown), leading to the conclusion that other components of the intestinal
microbiota are necessary for colitis development (although interactions of other enteric
microbes with Helicobacter spp. are possible).
To definitively confirm the microbiota dependence for colitis development, Nfil3−/− mice
were derived germ free (GF). Importantly, GF Nfil3−/− mice did not manifest colitis at 6
months of age (Fig. 7C, left) and colonic explant cultures produce low levels of IL-12p40
(Fig. 7D, left). However, upon transition to conventional housing (GF-CNV), Nfil3−/− mice
demonstrated histologic colitis (Fig. 7C, right), and colonic explant cultures produced
increased IL-12p40 (Fig. 7D, right) at 14 days, compared to similarly transitioned GF-CNV
WT mice.
DISCUSSION
Here we report that NFIL3 deficiency, akin to IL-10 deficiency (17), results in the
development of spontaneous colitis in mice. Immunohistochemistry showed that F4/80+
macrophages are predominant amongst the infiltrating inflammatory cells in the colons of
inflamed Nfil3−/− mice. Colonic inflammation in Nfil3−/− mice correlated with increased
colonic expression of innate derived cytokines TNF and IL-12p40, both central to human
IBD pathogenesis. Moreover, colonic CD11b+ cells, comprising mainly macrophages, are
the major source of increased IL-12p40 in Nfil3−/− mice. Increased expression of IFN-γ and
IL-17 in Nfil3−/− mice is consistent with the hypothesis that NFIL3 deficiency leads to a
pathogenic inflammatory Th1 and Th17 immune response. This inflammatory T cell
phenotype is driven by innate interactions with the enteric microbiota, as Nfil3−/− mice
crossed with Il12b−/− mice do not develop colitis. Two recent papers reported that NFIL3
regulates Th2 cytokine production in T cells but does not affect Th1 and Th17 cytokines
(26, 27), providing further evidence that the lack of NFIL3 in T cells does not directly
explain the increased Th1/Th17 response in Nfil3−/− mice.
The enteric microbiota and IL-10 are co-factors for NFIL3 expression in the intestine (29,
30). Indeed, we found colonic CD11b+ LPMC isolated from Nfil3−/− mice produced higher
amounts of Il12b mRNA than WT CD11b+ colonic macrophages. In human IBD, intestinal
CD14+ macrophages are the main producers of pro-inflammatory cytokines including IL-12
family members. We previously demonstrated that NFIL3 expression was lower in CD14+
LPMC isolated from patients with CD and UC compared with non-inflammatory controls
undergoing surgical resection (30), and intestinal NFIL3 expression inversely correlated
with higher amounts IL-12p40 in mice and humans (30). Increased colonic expression of
IL-10 was detected in Nfil3−/− mice, suggesting that even in the presence of abundant IL-10,
the loss of the downstream NFIL3 pathway cannot be overcome by increased local amounts
of IL-10. This notion is consistent with our data showing that IL-10 and NFIL3 mediate
cooperative but independent functions in macrophages and in vivo; IL-10 potently inhibited
Il12b to the same extent in WT, Nfil3−/−, and Nfil3−/− × Il10−/− macrophages arguing that
IL-10-dependent, NFIL3-independent pathways can regulate IL-12p40 production.
Furthermore, Nfil3−/− × Il10−/− mice developed severe colitis at an early age, demonstrating
non-overlapping homeostatic functions of NFIL3 and IL-10. However, the NFIL3-
independent pathways are not sufficient to prevent colitis in mice able to express IL-10.
Although T cells were necessary for colitis development, the critical role of innate immune
contributions in directing the inflammatory T cell response was conclusively demonstrated
through several lines of experimental evidence. First, Nfil3−/− × Il12b−/− mice were
protected from colitis. Moreover, Nfil3−/− × Rag1−/− mice developed worse colitis than
Rag1−/− mice when adoptively transferred with unfractionated WT CD4+ T cells. NFIL3
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was shown to be essential for NK cell development; therefore, Nfil3−/− mice lack peripheral
NK1.1+ NK cells (23, 24). Recently, Lang et al., demonstrated that the presence of NK cells
limited T cell expansion in vivo, and Nfil3−/− mice failed to regulate the expansion of IFNγ-
producing CD8+ cells (44). Thus it is possible that systemic NK cell deficiency leads to an
insufficient regulation of T cell responses in Nfil3−/− mice. We demonstrated that colonic
lamina propria from Nfil3−/− mice show a severe paucity of both RORγt+ and RORγt−
NKp46+ mucosal NK cells, and it was recently demonstrated that Nfil3−/− mice lack
intraepithelial NKp46+ ILC1 in the small intestine (45). Therefore, it is also possible that a
local mucosal NK cell deficiency plays a role in the pathogenesis of Nfil3−/− colitis that
requires further analysis. Interestingly, amongst multiple colonic cytokines we examined in
this study, IL-22 was the only cytokine that was not increased. IL-22 is largely produced by
RORγt+NKp46+ cells in the gut (NK22 cells) and is implicated in intestinal immune
homeostasis (39, 46). Therefore, lack of IL-22 induction may reflect the inability of Nfil3−/−
mice to properly respond to and resolve inflammation through IL-22. Further study is
needed to unravel the role of mucosal NK cells and IL-22 in the development of
spontaneous colitis in Nfil3−/− mice. Taken together, our study suggests that lack of NFIL3
in non-lymphocyte populations is essential for the development of colitis in Nfil3−/− mice
through subsequent Th1/Th17-biased acquired immune responses. Macrophages and
mucosal NK cells may play key roles in this process, and an imbalance in IL-12p40 and
IL-22 may be factors bridging innate immune dysfunction and T cell polarization described
in this study.
Colitis in Nfil3−/− mice is dependent on the presence and composition of the enteric
microbiota. Nfil3−/− mice demonstrated incomplete penetrance of colitis in the UNC facility,
and there was a marked difference in penetrance and severity of disease between institutions
maintaining the same strain of Nfil3−/− mice (University of Iowa) (28) or at St. Jude
Children’s Research Hospital where a different Nfil3−/− mouse is maintained (24, 31).
Importantly, the four described NFIL3-deficient mice (23, 24, 27, 28) have the same
phenotypes, arguing that the microbiota at a given location is a key non-genetic factor in
determining whether colitis develops. Many of the currently available murine models of
IBDs also exhibit incomplete penetrance and variable severity of disease (47). Hence,
compositional differences between enteric microbiota are the most plausible environmental
determinants for the development of colitis in different models at different sites.
Importantly, our GF Nfil3−/− mice do not manifest colitis at 6 months of age, and colonic
explant cultures produce low levels of IL-12p40, conclusively demonstrating a role for the
microbiota in colitis pathogenesis in this model. Non-H. hepaticus (H. hepaticus is routinely
screened by all facilities) Helicobacter spp. were ubiquitously present in the UNC and Iowa
colonies, leading to the conclusion that other components of the intestinal microbiota are
necessary for colitis development, although interactions of distinct enteric microbes with
Helicobacter spp. leading to colitis are possible. Moreover, components of the enteric
microbiota that colonize Nfil3−/− (and by inference WT) mice at the UNC facility not
present in the Iowa facility are colitogenic in Nfil3−/− mice. Further studies to characterize
the enteric microbial communities in WT and in Nfil3−/− mice at different facilities with
different colitis penetrance are likely to provide important insights into gene-environment
relationships relevant to human IBD pathogenesis.
Absence of colitis development in other institutions also raised a critical question for the
essential role for Nfil3 in the development of colitis. Therefore, we also generated Nfil3/Il10
DKO in St. Jude Children’s Research Hospital. The DKO demonstrate more severe and
more consistent colitis than the Il10−/− counterparts as we saw at UNC, despite the absence
of clinically apparent colitis in Nfil3 singles (data not shown). The DKOs also needed to be
euthanized at an early age due to severity of disease with very high prevalence of rectal
prolapse. This clear contrast of penetrance between Il10/Nfil3 DKO (complete penetrance)
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and singles (incomplete) across the different institutions elegantly shows the compensating/
interacting roles of IL-10 and NFIL3, and provides a model for elucidating multi-hit
mechanisms by multiple IBD susceptibility genes.
Several genes in pathways regulating the expression and/or function of the cytokines IL-10,
IL-12 and IL-23 contribute to IBD susceptibility (IL10, IL23R, IL12B, IL12RB1, STAT3,
JAK2, TYK2, HCK) (10, 18, 32). Work from our group and others have shown that other
IBD susceptibility genes are functionally embedded in these pathways (IFNG, IRF1, REL,
CEBPB) (32, 48–51). Moreover, the NFIL3 risk polymorphism is relatively common,
present in 70% of IBD cases; thus, approximately 50% of cases are homozygous for the risk
allele and 10% homozygous for the protective allele. Hence, we speculate that NFIL3 may
be one gene of many that affects IL12B expression in human IBD, with polymorphisms
leading to an incremental increase in IBD susceptibility. Moreover, there may be rare
genetic variants of NFIL3, akin to recently described IL-10 and IL-10 receptor
polymorphisms, which underlie a severe clinical phenotype such as very early onset IBD
(19).
Collectively, our results show that excessive IL-12p40 production in Nfil3−/− colonic
macrophages in response to the enteric microbiota is a key trigger that leads to an
exaggerated intestinal Th1/Th17 response, resulting in colitis development. As NFIL3 is a
human IBD susceptibility gene, the Nfil3−/− mouse is a new model to understand how a
genetic defect in a transcriptional repressor in innate immune cells leads to dysregulated T
cell inflammatory responses to the enteric microbiota. Furthermore, NFIL3 may be a useful
therapeutic target for human IBD given its central homeostatic functions in the intestines.
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Figure 1. Nfil3−/− mice develop spontaneous colitis
(A) Colon length of 12–18 week-old Nfil3−/− (n = 14) and age-matched WT (n = 8) mice
was measured. *, p<0.05 versus WT. (B) Prevalence of rectal prolapse was plotted (WT, n =
25; Nfil3−/−, n = 41). p<0.05 versus WT. (C) Histological severity (WT, n = 4; Nfil3−/−, n =
14) was scored based on Berg’s score. **, p<0.005 versus WT. (D, E) Colonic epithelium,
H&E (20× magnification). Photomicrographs of colonic mucosa taken at the same
magnification compared to WT mouse colons (D) demonstrate significant mucosal
hypertrophy with crypt elongation and decreased goblet cells in the Nfil3−/− (E) mouse
colons. (F) Colon, H&E (40× magnification). Inflammation in Nfil3−/− colons was
characterized by multifocal aggregates of inflammatory cells that extended transmurally to
the submucosa (G) Colon, H&E (4× magnification). Areas of ulceration (arrow) were also
occasionally observed. (H) Colon, H&E (40× magnification). In Nfil3−/− the inflammation
in the lamina propria was occasionally organized into de novo lymphoid follicles and
occasional multinucleated giant cells (arrow) were observed.
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Figure 2. Characterization of cytokine profile in the colon and serum in Nfil3−/− mice
(A) Colonic explants (WT, n = 9; Nfil3−/−, n = 11) were assayed for spontaneous secretion
of cytokines. Colons were isolated from WT and Nfil3−/− mice, cleaned, and processed for
intestinal tissue explant cultures as described in Experimental Procedures. Tissue fragments
(approximately 0.05 g dry weight) were incubated in 1 ml of RPMI 1640 supplemented with
1% antibiotics and 10% FBS. Supernatants were collected after 24 h and spontaneous
secretion of cytokines was measured by Multiplex. Values were normalized to dry weight of
the colonic explants (pg/ml/100 mg). (B) Colonic mRNA from WT (n = 7) and Nfil3−/− (n =
7) mice was extracted and expression of Il12b, Tnf, Ifng, Il17 and Il10 mRNA was assessed
by real-time RT-PCR. Results are expressed as relative expression normalized to β-actin.
(C) Serum cytokine concentration in WT (n = 9) and Nfil3−/− (n = 9) mice was measured by
Multiplex. (D) Correlation of serum and colonic tissue explant IL-12p40 in 12–18 week old
Nfil3−/− mice (n = 11). R2=0.8883, p<0.0001. (E) Correlation of histological score and
colonic tissue explant IL-12p40 in 12–18 week old Nfil3−/− mice (n = 11). R2=0.625,
p<0.005. (F) Correlation of serum IL-12p40 and histological score in 12–18 week old
Nfil3−/− mice (n = 11). R2=0.7914, p<0.0005.
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Figure 3. Characterization of increased inflammatory cell infiltration in the colon of Nfil3−/−
mice
(A) Fluorescence immunohistochemistry in colonic tissues from WT and Nfil3−/− mice was
performed for F4/80, CD11c, CD3, and B220 (Green). Specimens were counterstained with
DAPI (Blue). (B) Expression relative to β-actin of Il12b, Il23a, Tnf and Il10 transcripts in
CD11b+ and CD11b− LPMC from WT and Nfil3−/− mice. Results represent 3 independent
experiments. (C) LPMCs were isolated from WT and Nfil3−/− colons and stimulated with
phorbol myristate acetate (100 ng/ml) and ionomycin (1 mg/ml) in the presence of monensin
for 4 hours. Representative patterns for intracellular IFN-g and IL-17 in gated CD3+CD4+
lymphocytes from 3 independent experiments are shown. (D) Quantification of IFN-γ- and
IL-17A-positive cells in CD3+CD4+ lymphocytes from WT and Nfil3−/− LPMCs. Data are
presented as percentage of IFN-γ- or IL-17A-positive cells in gated CD3+CD4+
lymphocytes (mean ± SEM from 3 independent experiments). *, p<0.05; ***, p<0.0005
versus WT. (E) Representative patterns for intracellular FoxP3 staining in gated CD3+CD4+
lymphocytes from 3 independent experiments are shown.
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Figure 4. Nfil3−/− mice show decreased mucosal NK cells and LTi subpopulation
(A) CD4+ Colonic LPMCs were isolated and analyzed for CD3 and NK1.1. Lymphocytes
were gated by forward and side scatter and CD45 expression. (B) Colonic LPMCs were
isolated and analyzed for CD3, NKp46 and CD4 in combination with intracellular RORγt by
flow cytometry. Lymphocytes were gated by forward- and side-scatter and further gated in
CD3-negative cells (middle), CD3-negative NKp46-negative cells (right). (C) Colonic
explant cultures were analyzed for IL-22 expression by ELISA (WT, n = 6; Nfil3−/−, n = 7)
and colonic tissue was analyzed for Il22 expression by RT-PCR (WT, n = 6; Nfil3−/−, n = 7).
NS, not significant versus WT.
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Figure 5. IL-10 and NFIL3 independently regulate IL-12p40 in BMDMs and in vivo
(A) WT and Nfil3−/− BMDMs were stimulated with LPS (10 ng/ml) in the presence or
absence of IL-10 (1 ng/ml). Supernatants were harvested 24 hours post-LPS stimulation and
analyzed for IL-12p40 by ELISA. Results are presented as percent IL-12p40 by LPS in the
presence of IL-10 relative to LPS alone (mean ± SEM from 4 independent experiments).
NS, not significant versus WT. (B) WT, Nfil3−/−, Il10−/−, and Nfil3/Il10−/− double knockout
(NIDKO) BMDMs were stimulated with LPS (10 ng/ml) for 24 hours and IL-12p40 in the
supernatants were analyzed by ELISA. Results are presented as mean ± SEM from at least 4
independent experiments. *, p<0.05 versus NIDKO. (C) Il10−/− and NIDKO BMDMs were
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stimulated with LPS (10 ng/ml) in the presence or absence of IL-10 (1 ng/ml) for 24 hours
and analyzed for IL-12p40 by ELISA. Results are presented as percent IL-12p40 by LPS in
the presence of IL-10 relative to LPS alone (mean ± SEM from 4 independent experiments).
NS, not significant versus Il10−/−. (D) Quantitative histological scores from WT (n = 4),
Nfil3−/− (n = 14), Il10−/− (n = 6) and NIDKO (n = 6) mice were given. **, p<0.005 versus
NIDKO. (E) Comparison of spontaneous secretion of IL-12p40 by colonic explants from
12–18 week old WT (n = 7), Nfil3−/− (n = 13), Il10−/− (n = 6) and 5-week-old NIDKO (n =
6) mice. Values were normalized to dry weight of the colonic explants (ng/ml/100 mg). *,
p<0.05; **, p<0.005 versus NIDKO. (F) Colon lengths from WT (n = 8), Nfil3−/− (n = 14),
Il10−/− (n = 6) and NIDKO (n = 6) mice were measured. *, p<0.05 versus NIDKO.
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Figure 6. Lymphocytes are necessary for the development of colitis in Nfil3−/− mice
(A) Nfil3/Rag1 double knockout (NRDKO) mice were generated and histological scores
were assigned at 16 weeks of age (WT, n = 4; Nfil3−/−, n = 14; Rag1−/−, n = 8; NRDKO, n =
11). **, p<0.005 versus NRDKO. (B) Comparison of spontaneous secretion of IL-12p40 by
colonic explants from WT (n = 7), Nfil3−/− (n = 13), Rag1−/− (n = 8) and NRDKO (n = 11)
mice. *, p<0.05; NS, not significant versus NRDKO. (C–I) Rag1−/− (n = 7) and NRDKO (n
= 6) mice were given 1×106 unfractionated CD4+ T cells by i.p. injection and development
of colitis was monitored over 4 weeks. (C) Body weight expressed as a percentage of the
total body weight on Day 0 of the T cell transfer was measured. ***, p<0.0005 versus
Rag1−/−. (D) Clinical scores were measured at time of sacrifice as described in Experimental
Procedures. ***, p<0.0005 versus Rag1−/−. (E) Colon lengths were measured. ***,
p<0.0005 versus Rag1−/−. (F) Colon, H&E (10× magnification). Representative
photomicrographs from Rag1−/− and NRDKO mice given unfractionated CD4+ T cells. (G)
Quantitative histological scores were given. ***, p<0.0005 versus Rag1−/−. (H) Comparison
of spontaneous secretion of IL-12p40 by colonic explants from Rag1−/− (n = 7) and NRDKO
(n = 6) mice given unfractionated CD4+ T cells. *, p<0.05 versus Rag1−/−. (I) Comparison
of spontaneous secretion of IFN-γ by colonic explants. ***, p<0.0005 versus Rag1−/−.
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Figure 7. Development of colitis in Nfil3−/− mice requires the microbiota and is driven by
IL-12p40
(A,B) Nfil3/Il12b double knockout (DKO) mice were generated and monitored for colitis
development. (A) Colon lengths were measured at 16 weeks of age (WT, n = 8; Nfil3−/−, n =
14; Il12b−/−, n = 8; DKO, n = 13). ***, p<0.0005 versus Nfil3−/−. (B) Histological scores
were assigned at 16 weeks of age (WT, n = 4; Nfil3−/−, n = 14; Il12b−/−, n = 8; DKO, n =
13). **, p<0.005 versus DKO. (C,D) Germ free (GF) Nfil3−/− were generated and monitored
for colitis (WT, n = 12; Nfil3−/−, n = 6). Additionally, GF WT (n = 6) and Nfil3−/− (n = 4)
were transitioned to conventional housing (GF to CNV) and monitored for colitis
development for 14 days. (C) Histological scores were assigned. **, p<0.005 versus GF-
CNV WT. (D) Comparison of spontaneous secretion of IL-12p40 by colonic explants. *,
p<0.05 versus GF-CNV WT.
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